de Medina M, Ashby M, Schlüter V, Hill M, Leclerq B, Pennell J P, Jeffers L J, Reddy K R, Schiff E R, Hess G, Perez G O
Division of Hepatology, University of Miami School of Medicine and Veterans Administration Medical Center, FL 33125, USA. mednet.med.miami.edu.
Am J Kidney Dis. 1998 Feb;31(2):224-6. doi: 10.1053/ajkd.1998.v31.pm9469491.
An RNA virus designated hepatitis G virus (HGV) has been recently identified in patients with acute and chronic liver disease. HGV is transfusion transmissible, it has global distribution, and it is present in the volunteer blood donor population in the United States. One hundred sixty patients undergoing maintenance hemodialysis at the University of Miami-affiliated unit were evaluated. There were 99 men and 61 women ranging in age from 22 to 80 years. Sixty percent had a history of blood transfusion, 6% had a history of drug abuse, and 9% were infected with the human immunodeficiency virus. HGV-RNA was detected by reverse-transcriptase polymerase chain reaction with amplification of two independent regions (5'-nontranslated region and NS5a coding region). Detection of digoxigenin-labeled amplification products with specific capture probes to the coding and noncoding regions was performed with the Enzymun-test DNA on an ES-300 Immunoassay System (Boehringer-Mannheim, Mannheim, Germany). Hepatitis C antibodies were measured with anti-hepatitis C virus enzyme-linked immunosorbent third-generation assays and hepatitis C virus RNA by reverse-transcriptase polymerase chain reaction. There were 32 (20%) patients with detectable HGV RNA with both primer pairs. Because of possible mutations, the HGV virus may be detectable only with one primer pair. We considered the latter as indeterminate: 12 had detectable levels to the NS5a region only, seven to the 5'-nontranslated region, and six had borderline results. Detectable and indeterminate samples were confirmed by repeat measurements in a new blood sample. Seven of 24 (29%) patients with detectable hepatitis C virus RNA had coexisting HGV with one or both HGV primer pairs (four with both and three with one). Five patients were hepatitis B surface antigen positive and HGV negative. We conclude that HGV infection is prevalent in our dialysis patients. The clinical significance of HGV infection remains to be established.
最近在急慢性肝病患者中发现了一种名为庚型肝炎病毒(HGV)的RNA病毒。HGV可通过输血传播,在全球范围内均有分布,在美国的无偿献血人群中也有发现。对迈阿密大学附属医院接受维持性血液透析的160名患者进行了评估。其中男性99名,女性61名,年龄在22岁至80岁之间。60%的患者有输血史,6%有药物滥用史,9%感染了人类免疫缺陷病毒。通过逆转录聚合酶链反应检测HGV-RNA,扩增两个独立区域(5'-非翻译区和NS5a编码区)。使用ES-300免疫分析系统(德国曼海姆宝灵曼公司)上的酶免疫检测DNA,用针对编码区和非编码区的特异性捕获探针检测地高辛标记的扩增产物。用抗丙型肝炎病毒酶联免疫吸附第三代检测法检测丙型肝炎抗体,并用逆转录聚合酶链反应检测丙型肝炎病毒RNA。使用两种引物对时,有32名(20%)患者可检测到HGV RNA。由于可能发生突变,HGV病毒可能仅用一种引物对才能检测到。我们将后者视为不确定结果:12名患者仅NS5a区域可检测到,7名患者5'-非翻译区可检测到,6名患者结果处于临界值。通过对新血样重复检测来确认可检测和不确定的样本。在24名可检测到丙型肝炎病毒RNA的患者中,有7名(29%)同时感染了HGV,其中一种或两种HGV引物对均可检测到(4名两种引物对均可检测到,3名一种引物对可检测到)。5名患者乙肝表面抗原阳性且HGV阴性。我们得出结论,HGV感染在我们的透析患者中很普遍。HGV感染的临床意义尚待确定。